Daliresp 500 ug/1 (Roflumilast TABLET) 500 ug/1

Daliresp 500 µg tablets contain roflumilast, a medication used to manage chronic obstructive pulmonary disease (COPD). This oral treatment helps reduce inflammation in the lungs, aiding breathing. Learn more about roflumilast uses and benefits.

Strength

500 ug/1

Pack Size

90 TABLET in 1 BOTTLE, PLASTIC (0310-0095-90)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daliresp 500 µg tablets are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Roflumilast, the active ingredient, works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms like wheezing and shortness of breath. This medication is often prescribed for long-term management of COPD, particularly in patients with chronic bronchitis. Understanding what roflumilast is used for can help patients manage their condition more effectively.

Side Effects

Common effects of Daliresp 500 µg tablets may include gastrointestinal issues such as diarrhea, nausea, and weight loss. Some users might also experience headaches or insomnia. These effects can vary from person to person, and not everyone will experience them. It's important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

Daliresp 500 µg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight and out of reach of children. Always follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not stop or change the dosage without consulting a healthcare professional.

Avoid Interactions

Daliresp 500 µg tablets may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It's important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol consumption should also be discussed with your healthcare provider, as it may affect the efficacy or safety of roflumilast.

References

Frequently Asked Questions

Daliresp 500 µg tablets are used for the maintenance treatment of chronic obstructive pulmonary disease (COPD), helping to reduce lung inflammation and improve breathing.

Daliresp 500 µg tablets are taken orally, typically once daily. Follow the administration instructions provided by your healthcare provider.

Common side effects may include gastrointestinal issues like diarrhea and nausea, as well as headaches and insomnia.

It's important to discuss alcohol consumption with your healthcare provider, as it may interact with roflumilast.

Store Daliresp 500 µg tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.